Abstract
The committed step in the biosynthesis of isoprenoids is catalyzed by HMG-CoA reductase. Recently determined structures of the distantly related bacterial and mammalian HMG-CoA reductases have revealed two distinct classes of the protein with differently formed active sites and oligomeric states. An appreciation of the remarkable differences in the active site architecture may ultimately lead to the development of novel antibacterial agents.
Original language | English |
---|---|
Pages (from-to) | 746-751 |
Number of pages | 6 |
Journal | Current Opinion in Structural Biology |
Volume | 11 |
Issue number | 6 |
DOIs | |
State | Published - Dec 1 2001 |